Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Viridos, formerly known as Synthetic Genomics, pioneers the use of engineered microalgae to produce low-carbon intensity biofuels for heavy transportation sectors. The company has achieved record levels of algae oil productivity at scale and continues to optimize yield-per-acre and downstream processing. Its innovations have led to more than 100 patents and several spin-offs in synthetic biology tools, including automated DNA synthesis instruments. Viridos' algal biofuel can deliver a >70% reduction in greenhouse gas emissions compared to fossil fuels[6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Viridos.